Phospholipase A2 (sPLA2) is an important class of interfacial enzyme involved in key biological processes such as signal
transduction and lipid metabolism. Pharmacologic modulation of sPLA2 represents an attractive therapeutic strategy for
several medical diseases including cancer, but efforts toward this goal have been stymied by the limited knowledge about the link
between how sPLA2 members interact with target lipid membranes and their respective physiological functions. To gain insight
into the biophysical mechanism underlying membrane association of sPLA2 enzymes, we developed a model membrane biosensor
platform to probe the role of membrane electrostatics in this process. Real-time monitoring of the membrane association step with
the quartz crystal microbalance with energy dissipation (QCM-D) technique enabled us to identify a novel bilayer-disrupting
behavior that is dependent on membrane electrostatics. The data identified that 1) enzyme adsorption to model membranes is
primarily mediated by non-electrostatic interactions; 2) nonhydrolytic bilayer-disruption can follow enzyme adsorption; and 3)
this disruptive activity is directly related to electrostatic interactions. Based on these findings, we conclude that interfacial binding
of sPLA2 enzymes is a dynamic process, and identify promising opportunities for therapeutic intervention as well as engineering
approaches for sPLA2-triggered liposomal drug delivery.
Jackman attended the University of Florida where he earned a bachelor?s degree with highest honors in chemistry, and was a member of Phi Beta Kappa. During his undergraduate studies, he was named a Beckman Scholar and pursued extensive research at Stanford University on the design and application of model membranes for biomedicine. Mr. Jackman then began his doctoral studies in biomedical engineering at Harvard University- Massachusetts Institute of Technology as an NSF Graduate Fellow, before transferring to Nanyang Technological University in Singapore in order to become involved in the emerging Asian biotechnology community, and to reunite with his former mentor from Stanford, Dr. Nam-Joon Cho.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals